“Making money in the market is really about investors with confidence taking it from those that lack it. Knowing that insiders are buying and not selling gives me that added confidence”, Harvey Sax, Top 10 long short equity fund manager according to BarclayHedge
Jazz Pharmaceutical Director Seamus Mulligan bought 50,000 shares at $111.08. Before investors pile in behind that enforcement, it's worth considering Mulligan bought 50,000 shares back in 11/15/18…
We use cookies to ensure that we give you the best experience on our website. By accessing this site, you agree to be bound by the terms of service, copyright disclaimer and privacy notice. OkPrivacy policy